Sickle Cell Disease
(3 hrs. CPE)

Home Sickle Cell Disease
(3 hrs. CPE)

Sickle Cell Disease
(3 hrs. CPE)

$75.00

EDUCATIONAL NEEDS

Sickle cell disease (SCD) affects millions of people throughout the world and is particularly common among those whose ancestors came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere (South America, the Caribbean, and Central America); Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy. It is estimated that: SCD affects approximately 100,000 Americans. People with SCD have less access to comprehensive team care than people with other genetic disorders. Clinical research continues to explore ways to address unmet needs in managing SCD. New therapies are being researched that will focus on treating SCD at the genetic level.

As a part of the biennial renewal, consultant pharmacists are required to complete 24 hours of continuing education, which may be in 3-hour blocks. The three-hour activity may be applied towards the twenty-four-hour continuing education requirement for pharmacists. (64B16-26.103)

EDUCATIONAL OBJECTIVES

At the completion of this activity, pharmacists will be able to: Define sickle cell disease (SCD); List various types of sickle cell; Describe clinical signs associated with SCD; Outline complications of SCD; Counsel patients on lifestyle modifications and preventive strategies; Identify therapeutic agents used to manage SCD.

Add to Wishlist
Category: Tag:

Description

TARGET AUDIENCE

This home study activity is targeted to pharmacists.

 

ACCREDITATION STATEMENT

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Three (3) contact hours are available upon completion of the posttest questions and evaluation form.  Participants must pass the exam with a score of 70% or better. There will be an additional opportunity to retake the posttest if the participant does not pass.  This is an ACPE knowledge-based activity.  Initial Release Date: December 10, 2023.  Expiration Date:  December 10, 2026. UAN:  0675-0000-23-032-H01-P. Florida Board of Pharmacy approval number 20-1137500.


AUTHORS

Munachimso Okoli, Pharm D Candidate 2024, Florida A&M University, College of Pharmacy
Gwendolyn Keller, PhD, Author, Editor, Retired Educator               

FINANCIAL DISCLOSURE

There are not any conflicts of interests in relation to this home study activity.

DISCLOSURE DECLARATION

It is the policy of iCARE Pharmacy Services, Inc. to ensure accurate and non-bias information in accordance with the latest available evidence-based scientific knowledge in all continuing education activities.

The author(s) involved have made reasonable efforts to ensure that information contained herein is accurate and current in accordance with the latest available scientific knowledge at the time of this activity. Participants are advised to review the manufacturer's package insert prior to dispensing or administering any medication/vaccine as information regarding medications (administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to change. Special precautions should be taken when a medication is new, highly toxic, or unfamiliar to the participant. The information presented in this activity is not meant to serve as a guideline for patient management. Participants have an implied responsibility to use the newly acquired information to enhance their knowledge base, meet their personal/professional development and improve patient outcomes.

Related products